Literature DB >> 9804306

Metabolic regulation of endogenous adenosine release from single neurons.

J M Brundege1, T V Dunwiddie.   

Abstract

The mechanisms that regulate adenosine release in the brain are not well understood. The present study investigated the hypothesis that individual neurons can generate and release sufficient adenosine to regulate their synaptic inputs. We utilized the whole-cell recording technique to apply enzyme inhibitors and nucleotides directly into the cytoplasm of single rat hippocampal CA1 pyramidal neurons. Cytoplasmic delivery of adenosine induced the release of sufficient adenosine to inhibit excitatory synaptic inputs. However, intracellular delivery of nucleotides and enzyme inhibitors failed to increase adenosine receptor-mediated inhibition. These data suggest that while pyramidal neurons in the hippocampus are capable of releasing large amounts of adenosine into the extracellular space, they do not readily form adenosine from endogenous sources.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804306     DOI: 10.1097/00001756-199809140-00016

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Contribution of extrasynaptic N-methyl-D-aspartate and adenosine A1 receptors in the generation of dendritic glutamate-mediated plateau potentials.

Authors:  Katerina D Oikonomou; Mandakini B Singh; Matthew T Rich; Shaina M Short; Srdjan D Antic
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

2.  Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity.

Authors:  Ditte Lovatt; Qiwu Xu; Wei Liu; Takahiro Takano; Nathan A Smith; Jurgen Schnermann; Kim Tieu; Maiken Nedergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

3.  Why Does Sleep Slow-Wave Activity Increase After Extended Wake? Assessing the Effects of Increased Cortical Firing During Wake and Sleep.

Authors:  Alexander V Rodriguez; Chadd M Funk; Vladyslav V Vyazovskiy; Yuval Nir; Giulio Tononi; Chiara Cirelli
Journal:  J Neurosci       Date:  2016-12-07       Impact factor: 6.167

Review 4.  The Use of Caffeine by People with Epilepsy: the Myths and the Evidence.

Authors:  Prisca R Bauer; Josemir W Sander
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-14       Impact factor: 5.081

5.  Release of adenosine and ATP during ischemia and epilepsy.

Authors:  Nicholas Dale; Bruno G Frenguelli
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 6.  Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

Authors:  K Janes; A M Symons-Liguori; K A Jacobson; D Salvemini
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

7.  Cell-subtype-specific changes in adenosine pathways in schizophrenia.

Authors:  Sinead Marie O'Donovan; Courtney Sullivan; Rachael Koene; Emily Devine; Kathryn Hasselfeld; Cassidy Lynn Moody; Robert Erne McCullumsmith
Journal:  Neuropsychopharmacology       Date:  2018-02-26       Impact factor: 7.853

Review 8.  The purinergic neurotransmitter revisited: a single substance or multiple players?

Authors:  Violeta N Mutafova-Yambolieva; Leonie Durnin
Journal:  Pharmacol Ther       Date:  2014-06-02       Impact factor: 12.310

9.  Ecto-5'-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions.

Authors:  Elisabete Augusto; Marco Matos; Jean Sévigny; Ali El-Tayeb; Margaret S Bynoe; Christa E Müller; Rodrigo A Cunha; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2013-07-10       Impact factor: 6.167

10.  Activity-dependent release of adenosine: a critical re-evaluation of mechanism.

Authors:  Mark Wall; Nicholas Dale
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.